Previous Page  20 / 22 Next Page
Information
Show Menu
Previous Page 20 / 22 Next Page
Page Background

Endocrinology 2018

Journal of Clinical and Molecular Endocrinology

ISSN: 2572-5432

Page 59

August 09-10, 2018

Madrid, Spain

11

th

International Conference on

Endocrinology and

Diabetology

D

iabetes mellitus (DM) is a degenerative disease that

continues to increase its prevalence worldwide. Increased

cases of DM are influenced by several factors such as changes

in lifestyle, obesity and dietary society. Studies have shown

that central obesity is associated with insulin resistance (type II

DM). The purpose of this research is to know the difference of

waist circumference, waist hip ratio, glycemic index and fiber

in DM type II patient and other type. The research design used

was observational analytic with cross sectional approach on 58

samples.The investigationwasconducted fromApril toMay2017.

The data of waist circumference and waist hip ratio (WHR) were

collected by anthropometric measurement. Food consumption

data with glycemic index and fiber by filling in semi quantitative

form Food Frequency (FFQ). Data were analyzed using univariate

and bivariate independent t test. The results waist circumference

(p=0.86), waist hip ratio (WHR) (p=0.92), food consumption with

high glycemic index (p=0.14), index glycemic low (p=0.06), and

fiber consumption (p=0.97) (p>0.05) in patients with type II DM

and other types of DM. There are no differences in abdominal

circumference, waist circumference ratio, food consumption with

glycemic index and fiber consumption in patients with type II DM

and other types of DM. It is expected the participation of hospital

staff to patients with diabetes to provide information about the

benefits of glycemic index food and encouragement to maintain

weight, increase fiber consumption so that blood sugar levels can

be controlled.

nurfadhila.istighfara@gmail.com

Difference in waist circumference, waist hip ratio (whr),

glycemic index, and dietary fiber intake in patients with type II

diabetes mellitus and other types of diabetes mellitus

Nur Fadhila Istighfara

1

, Miratul Haya

2

and

Arie Krisnasary

3

1

University of Manchester, UK

J Clin Mol Endocrinol 2018, Volume 3

DOI: 10.21767/2572-5432-C2-006